Compile Data Set for Download or QSAR
Report error Found 158 Enz. Inhib. hit(s) with all data for entry = 12056
TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674739(US20240158369, Compound 46 | US20240158369, Compou...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674749(US20240158369, Compound 11)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674750(US20240158369, Compound 12)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674751(US20240158369, Compound 13)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674752(US20240158369, Compound 14)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674753(US20240158369, Compound 15)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674754(US20240158369, Compound 16)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674755(US20240158369, Compound 17)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674756(US20240158369, Compound 18)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674757(US20240158369, Compound 19)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674758(US20240158369, Compound 20)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674759(US20240158369, Compound 21)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674760(US20240158369, Compound 22)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674761(US20240158369, Compound 23)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674762(US20240158369, Compound 24)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674763(US20240158369, Compound 25)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674764(US20240158369, Compound 26)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674765(US20240158369, Compound 27)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674766(US20240158369, Compound 28)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674767(US20240158369, Compound 29)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674768(US20240158369, Compound 30)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674769(US20240158369, Compound 31)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674770(US20240158369, Compound 32)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674771(US20240158369, Compound 33)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674772(US20240158369, Compound 34)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674773(US20240158369, Compound 35)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674774(US20240158369, Compound 36)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674775(US20240158369, Compound 37)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674776(US20240158369, Compound 38)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674777(US20240158369, Compound 39)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674778(US20240158369, Compound 40)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674780(US20240158369, Compound 42)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674781(US20240158369, Compound 43)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674782(US20240158369, Compound 44)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674783(US20240158369, Compound 45)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674739(US20240158369, Compound 46 | US20240158369, Compou...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674785(US20240158369, Compound 47)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674786(US20240158369, Compound 48)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674787(US20240158369, Compound 49)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674788(US20240158369, Compound 50)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674789(US20240158369, Compound 51)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674790(US20240158369, Compound 52)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674791(US20240158369, Compound 53)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674792(US20240158369, Compound 54)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674793(US20240158369, Compound 55)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674794(US20240158369, Compound 56)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674795(US20240158369, Compound 57)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674796(US20240158369, Compound 58)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674797(US20240158369, Compound 59)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandPNGBDBM674798(US20240158369, Compound 60)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 158 total ) | Next | Last >>
Jump to: